分为实验组:糖尿病性白内障患者房水38份,包括无糖尿病视网膜病变组(non-diabetic retinopathy,NDR)房水25份和伴有非增生性糖尿病视网膜病变组(non-proliferative diabetic r...
基于32个网页-相关网页
...（EDV）、阻力指数（RI）,分析糖尿病视网膜病变（diabetic retinopathy DR）和糖尿病不伴视网膜病变（non-diabetic retinopathy,NDR）时其血流动力学的改变以及正常人不同年龄组血流参数的变化规律.
基于20个网页-相关网页
根据眼底荧光造影的结果分为糖尿病无视网膜病变(non-diabetic retinopathy,NDR)组、非增殖期糖尿病视网膜病变(non-proliferative diabetic retinopa...
基于18个网页-相关网页
...llitus (EDV)、阻力指数(RI),分析糖尿病视网膜病变(diabetic retinopathy DR)和糖尿病不伴视网膜病变(non-diabetic retinopathy,NDR)时其血流动力学的改变以及正常人不同年龄组血流参数的变化规律.
基于4个网页-相关网页
non-diabetic retinopathy NDR 无视网膜病变
Non diabetic retinopathy Retinopathy 非糖尿病视网膜病变
non-obvious diabetic retinopathy 无明显视网膜病变 ; 包括无明显视网膜病变
non-proliferating diabetic retinopathy 非增殖性糖尿病视网膜病变
Somatropin should not be used for growth promotion in pediatric patients with closed epiphysis or in patients with active proliferative or severe non - proliferative diabetic retinopathy.
生长激素不应用于儿科闭合骺患者，活性增生或严重非增生糖尿病视网膜病患者的生长促进。
Objective: to investigate the therapeutic effect of modified grid laser photocoagulation (MGLP) for the treatment of macular edema associated with non - proliferative diabetic retinopathy (NPDR).
目的：探讨改良格栅样光凝在治疗非增殖型糖尿病视网膜病变黄斑水肿中的疗效。
Of those there were 25 cases 50 eyes in proliferating diabetic retinopathy group and 25 cases 50 eyes in non - proliferating diabetic retinopathy group.
其中增殖性糖尿病视网膜病变组25例(50眼)；非增殖性糖尿病视网膜病变组25例(50眼)。
应用推荐